ABSTRACT
INTRODUCTION
Transcriptional activation of a gene locus leads to distinct changes in the structure of the surrounding chromatin. Active genes or gene clusters are located within regions of general DNase I sensitivity, which are not restricted to the coding region, but extend into 5' and 3' flanking chromatin (1 -3) . Active cisregulatory elements usually located within the domain of general DNase I sensitivity adopt a distinct non-nucleosomal conformation, which renders them hypersensitive with respect to DNase I digestion [For review: (4) ]. It is not known whether chromatin decondensation is autonomous and has to preceed the transcriptional activation of a gene, or whether the general DNase I sensitivity of active gene loci is the consequence of a topological constraint on the chromatin as a result of transcription itself (5) . The first model would imply a hierarchy of cisregulatory DNA elements some of which would function as master switches responsible for the initial, differentiation dependent commitment of a gene locus towards gene expression. Evidence for these type of regulatory elements comes from experiments describing the features of DNA elements having a dominant control function in the activation of gene expression, the locus control regions (LCRs). LCRs were first described in the human 3-globin gene cluster (6, 7) and have been detected in a variety of developmentally regulated genes (8) (9) (10) (11) (12) (13) (14) (15) . LCRs have transcriptional enhancer activity, are necessary for high level, tissue specific expression and direct transcription independent of the random chromosomal position of integrated transgenes (6, 16) . They are often associated with developmentally stable DNase I hypersensitive chromatin sites (DHSs), which are present before specific mRNA can be detected (7, 17, 18) . In the human 3-globin system the formation of DNase I sensitive chromatin is dependent on the presence of at least parts of the LCR (19) . However, chromatin analysis of deletion mutants of the chicken 3-globin locus in transgenic mice indicate the dependence of the establishment of generally DNase I sensitive chromatin on the presence of both the enhancer/LCR and the promoter (20) .
The chicken lysozyme gene, one of the major egg white protein genes is expressed in the oviduct. The same gene is also expressed in the myeloid lineage of the hematopoietic system. Expression is gradually switched on during macrophage differentiation, reaching its highest level in the mature, activated macrophage (21, 22) . Lysozyme gene transcription is regulated by a complex set of cis-regulatory DNA elements consisting of several tissue specific enhancers, a silencer and promoter elements (21) (22) (23) (24) (25) . The activity of these cis acting elements is marked by tissue specific DHSs (26) (27) (28) . The active gene locus including all cis acting elements is located within a domain of general DNase I sensitivity, which spans 24 kb (2) . The DNase I sensitive domain *To whom correspondence should be addressed 'Present address: Department of Cell Biology and Genetics, Erasmus University Rotterdam, dr. Molewaterplein 50, 3000 DR Rotterdam, The Netherlands k.) 1994 Oxford University Press is flanked by DNA sequences which have a high affinity for the nuclear matrix in vitro (29) . The domain border fragment containing the 5' matrix attachment region was shown to be able to stimulate transcription in stable transfections and to buffer linked reporter genes from chromosomal position effects (30, 31) . When the complete chicken lysozyme locus is introduced into the germline of mice it is expressed as a macrophage specific, independent regulatory unit regardless of its random position in the host genome (32) . We (23, 33, 34) . The activity of both enhancers is marked by the presence of a DHS in the chromatin of macrophage cells. The DHS at the -6.1 kb enhancer is present in all active or potentially active cell types (oviduct, all retrovirally transformed macrophage precursor cell lines and primary macrophages) regardless of the level of lysozyme mRNA (22, 27) . In contrast, the DHS at the -2.7 kb enhancer appears only in cells representing late stages of macrophage differentiation where the transcriptional activity of the lysozyme gene is high. It is not present in the oviduct (24, 27) . These results suggested a differential temporal regulation of the activity of the two enhancers during development (22) . Transfection assays have shown both enhancers to be tissue specifically active in myeloid cells (21, 23, 33, 34) . However, from these experiments it could not be decided whether the activation of the lysozyme locus during development can be mediated by the independent action of both enhancers or whether the activiation of the -2.7 kb enhancer and the subsequent activation of lysozyme gene expression is dependent on the previous function of the -6.1 kb enhancer. It is also not known whether position independent expression can be assigned to one or several cis acting elements.
In this report, we describe the role of these two regulatory regions and the domain border fragments with respect to the activation of the chicken lysozyme gene domain in macrophages of transgenic mice. We show that both enhancer regions do not act in a hierarchical order since they can individually activate the lysozyme gene in a tissue specific manner. In the presence of the complete set of regulatory sequences deletion of the domain border fragments has no consequences on macrophage specificity and copy number dependency of transgene expression. However, absence of the domain border fragments in constructs carrying incomplete regulatory units results in a higher incidence of ectopic expression. Copy number dependency of expression can not be assigned to a single regulatory element. Only the presence of the complete set of cis-regulatory sequences ensures position independency of transgene expression at random chromosomal positions.
MATERIALS AND METHODS
Construction of deletion mutants of the chicken lysozyme domain All constructs and their subsequent injected fragments were derived from plasmid polUlilys (32) . The XbaI-SmaI XS fragment was purified from a polyIIIilys plasmid in which the second XbaI site located in the second intron was inactivated (pfIhilys-X2). The Xba' (X') site shown in Figure IA Generation and characterization of transgenic mice The fragments carrying different parts of the chicken lysozyme gene domain were purified from vector sequences as described (36) and injected into fertilized oocytes from CBAxC57 bl mice (37) . Transgenic mice were identified by PCR analysis of tail DNA using chicken lysozyme specific primers and Southern blotting. Copy numbers of integrated transgenes were determined by phosphorimager analysis of genomic Southern blots from EcoRI digested genomic DNA hybridized simultaneously with a lysozyme specific probe recognizing a 2.7 kb EcoRI fragment located in the 3' half of the gene (35) and a Thyl probe (6) recognizing the endogenous mouse gene to control loading differences. Single copy mice in the KS-series were identified by cleavage of tail DNA with BamH1, which cuts only once in the integrated fragment. EcoRI (38) . RNA from cultured chicken cells and from primary mouse macrophages was prepared by the acid guanidinium thiocyanate-phenol-chloroform extraction method (39) . A 530 bp BstNI fragment spanning the promoter region served as a chicken lysozyme specific S1 hybridization probe (21) , a 320 bp BamHI -AvaI fragment from pHF(3A-1 (40) was used as a j-actin specific probe. S1 analysis for chicken lysozyme and ,3-actin mRNA was performed as described (32) . To construct a mouse lysozyme hybridization probe a 320 bp EcoRI-PstI fragment of plasmid pmLcl carrying the mouse lysozyme M cDNA (41), containing exons 1 and 2 was cloned into Bluescribe (M13+) and named pmLc2. A 315 bp BstNI fragment isolated from pmLc2 containing vector sequences provided a mouse lysozyme specific internal hybrilization probe. Hybridization with this probe was performed at 50°C overnight and digestion with 100 units Si nuclease was performed for 1.5 h at 37°C. Si resistant fragments were run on a 7.5% polyacrylamide/urea gel. SI hybridization signals were quantified by phosphorimager analysis. To determine the expression levels per gene copy SI hybridization signals for ,B-actin and chicken lysozyme were quantified. The chicken lysozyme expression value was then calibrated with respect to the 3-actin specific signal. To prove that the calculated expression level per gene copy in XS mice was correct, an SI hybridization assay was performed in which RNA samples from transgenic mouse macrophages were diluted with macrophage RNA from nontransgenic mice to contain the same amount of specific RNA as determined in the previous assay and the same amount of total RNA. The first SI hybridization assay containing the same amount of transgenic mouse macrophage RNA was then repeated.
Cell cultures HD1l cells (42) were grown in standard Iscove's medium supplemented with 8 % fetal calf serum and 2 % chicken serum. Mouse L-cell fibroblasts used to prepare conditioned medium were grown in Iscove's medium, 10% fetal calf serum. Primary mouse macrophages were prepared by peritoneal flush 4 days after injection of 3% Thioglycolate medium (Gibco) in PBS into the peritoneal cavity of transgenic mice. Cells were cultured overnight in Iscove's medium plus 10% L-cell conditioned medium (32) .
RESULTS
The generation of transgenic mouse lines carrying deletion mutants within the chicken lysozyme gene domain
We generated a series of transgenic mice carrying constructs in which one or several DNA elements of the complete lysozyme gene domain were deleted ( Figure IA ). Two constructs carry internal deletions. In one of them a 3.4 kb fragment containing the early -6.1 enhancer was removed (dXK). In addition this fragment included DNA sequences with no apparent cisregulatory function adopting a constitutive DHS at -7.9 kb in the chromatin of all cell types investigated to date. In the other construct a 2 kb fragment carrying three cis-regulatory elements including the -2.7 kb enhancer (dSS) was deleted. The latter deletion in addition removes the silencer element at -2.4 kb (43) and the steroid responsive element necessary for expression of the gene in the oviduct (44) . The DHSs marking the activity of the silencer is present in macrophage progenitor cells, non expressing cells and the oviduct (27) . Its disappearance parallels the appearance of the -2.7 kb DHS during macrophage maturation (22) . In mature primary macrophages only the -2.7 kb DHS is present and the -2.4 kb DHS is absent (27, 28) . In another series of constructs carrying either the complete set of cis acting elements or internal deletions as described above the 5' and 3' domain border fragments were removed (XS, KS, XSdSS). The 3' domain border fragment carries a DHS, which is only present in oviduct and non-expressing cells, but absent in macrophages (27) .
For each construct between 4 and 12 different mouse lines were generated ( Figure 1B Figure IA) is exclusively expressed in macrophages, spleen and in the brain. Brain expression is specific and is found in the same cell tpe in several independently investigated transgenic mouse lines (45) . Expression in spleen is due to the presence of macrophages in this organ (32, 45) . Within the limits of the assay, expression could not be found in any other cell type ( Figure 1B ). Without the upstream region harboring the early -6.1 kb enhancer (dXK) macrophage specific lysozyme expression is observed in three of five mouse lines ( XhoI. wt: mouse lines described in (32 could be detected in macrophages of all mouse lines. All mice except mouse 12 showed a significant level of brain expression (see also Figure 5 ). Expression in macrophages of four of seven mouse lines was higher than in brain ( Figure 2B, Figure 5A and Table 1 ) and one mouse expressed the transgene at a very low level ( Figure 2B , mouse 12 with 8 gene copies; see also Table 1 ). No lysozyme mRNA was found in any other tissue. Taken together, we conclude that deletion of either enhancer region from the chicken lysozyme domain does not disable transgene expression in macrophages.
The presence of the complete set of cis-regulatory sequences results in high level and macrophage specific expression Lysozyme DNA constructs carrying two copies of the 5' matrix attachment region flanking the -6.1 kb enhancer, the lysozyme promoter and the CAT reporter gene have in previous experiments been stably transfected into chicken promacrophage cells. They were expressed in a position independent manner with an exponential relationship between copy number and expression level. This result led to the hypothesis that the border elements buffer the chromatin mediated position effect usually observed after stable transfection (30) . We were interested to examine the role of the domain border fragments in the context of the whole lysozyme gene domain in the more stringent transgenic mouse system. The first construct we examined (XS) lacked the domain border fragments, but still carried all cis-regulatory sequences. All five different mouse lines carrying this construct expressed the transgene at a high level in macrophages (Figure 3 ). The expression pattern was very similar to that observed in mice carrying the wild type construct (32) . In addition, lysozyme expression levels followed transgene copy numbers (Table 1, Figure 4A ). Furthermore, we found lysozyme mRNA to be expressed ectopically. One mouse ( Figure 4A , mouse A5 with 54 gene copies) expressed the gene at different levels in thymus, spleen and lung but at a low level in macrophages. In four other mice lysozyme mRNA was found in the liver ( Figure 4A , mice B2 and C6 with 15 and 2 gene copies, respectively) or in the lung ( Figure 4A , mice A13 and BO with 1 and 2 gene copies, respectively). One mouse (C13 with 38 gene copies) expressed the gene at a very low level in all tissues analyzed (data not shown). Transgenic mice carrying a construct with only the -6.1 kb region (XSdSS) showed a similar expression pattern as mice carrying the dSS construct ( Figure 4B ). Expression in the brain could be observed in all mice including mouse 26 (a specific signal was visible after longer exposure of the film, data not shown). One mouse, however, expressed a very high level of lysozyme mRNA in the lung ( Figure 4B , mouse 28). In lung cells the three lysozyme specific transcriptional start sites at the promoter are not used with the same relative frequency as in macrophage cells. Only the +1/-2 and the -24 start sites are used, whereas macrophages use an additional start at -58 (47) . With both constructs a significantly increased incidence of nonspecific expression is observed when compared to mice carrying the same cis-regulatory elements plus the domain border fragments. Only 1 out of 11 expressing dXK and dSS mice expressed the lysozyme transgene ectopically, whereas this is the case for 7 out of 10 expressing KS and XSdSS mice ( Figure 1B ). Position independency of expression is a result of the cooperation of all cis-regulatory elements within the chicken lysozyme gene domain One of the key defmiitions of locus control regions is their ability to direct copy number dependent expression of transgenes irrespective of their random position of integration into host chromatin. We examined the precise transgene expression level in macrophages ( Figure 5A ) and determined the expression levels per gene copy ( ii~iIMiiiiiIJP The concerted action model for the correct function of transgene promoters The DHS pattern of the early -6.1 kb enhancer and the late -2.7 kb enhancer in various chicken cells suggested a stepwise activation of the gene locus during macrophage differentiation (22) . It was therefore speculated, that the -6.1 kb enhancer and not the -2.7 kb enhancer could act as a dominant control element (25) and by that being a prerequisite for the activation of the later acting cis-regulatory elements. The experiments described in this paper show, however, that if flanked by domain border fragments each individual enhancer region is by itself capable of activating lysozyme transcription in macrophage cells. The activity of one enhancer is not dependent on the previous function of the other, instead they cooperate.
We conclude that only the concerted action of all regulatory elements of a gene locus leads to a correct developmental regulation of a transgene. It is, therefore , no surprise that the transfer of transgenes on yeast artificial chromosomes (YACs) into the mouse germ line results in a correct regulation of transgenes (53, 54 
